04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The circumstances surrounding COVID-19 (commonly referred to as the “coronavirus”) are unfolding e...
Read More >
It’s hard to keep up with all the recent changes to labor and employment law. While the law always ...
Read More >
There has been a lot of talk about how much more pro-business the U.S. Department of Labor was going...
Read More >
The Boston Planning and Development Agency (“BPDA”) has approved an amendment to the Boston Zoning...
Read More >
In July, there were three significant developments affecting MEPs. A MEP, generally speaking, is a ...
Read More >
Merger review processes are being impacted worldwide as merger control authorities adapt to take acc...
Read More >